Free Trial

Sysmex Co. (OTCMKTS:SSMXY) Sees Significant Growth in Short Interest

Sysmex logo with Medical background

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 900 shares, a growth of 125.0% from the December 15th total of 400 shares. Based on an average daily volume of 216,100 shares, the short-interest ratio is currently 0.0 days.

Sysmex Trading Down 1.5 %

OTCMKTS SSMXY traded down $0.29 on Friday, reaching $18.63. The company had a trading volume of 57,517 shares, compared to its average volume of 90,856. Sysmex has a 52 week low of $14.38 and a 52 week high of $28.58. The stock's 50 day moving average is $19.44 and its 200-day moving average is $18.62. The company has a quick ratio of 2.42, a current ratio of 3.19 and a debt-to-equity ratio of 0.11. The stock has a market cap of $11.73 billion, a price-to-earnings ratio of 36.11 and a beta of 0.89.

About Sysmex

(Get Free Report)

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

Featured Stories

Should You Invest $1,000 in Sysmex Right Now?

Before you consider Sysmex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.

While Sysmex currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines